MONTEREY BIO ACQUISITION COR - COM (MTRY)

CUSIP: 61240F108

Q2 2022 13F Holders as of 30 Jun 2022

Type / Class
Equity / COM
Total 13F shares
11,347,076
Share change
+329,659
Total reported value
$113,637,000
Price per share
$10.02
Number of holders
44
Value change
+$3,311,801
Number of buys
11
Number of sells
10

Quarterly Holders Quick Answers

What is CUSIP 61240F108?
CUSIP 61240F108 identifies MTRY - MONTEREY BIO ACQUISITION COR - COM in SEC institutional holdings data.

Need full ownership history?
Open the full security ownership history page.

Institutional Holders of MONTEREY BIO ACQUISITION COR - COM (MTRY) as of Q2 2022

As of 30 Jun 2022, MONTEREY BIO ACQUISITION COR - COM (MTRY) was held by 44 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 11,347,076 shares. The largest 10 holders included Saba Capital Management, L.P., Periscope Capital Inc., Karpus Management, Inc., Shaolin Capital Management LLC, MMCAP International Inc. SPC, ATW SPAC MANAGEMENT LLC, BOOTHBAY FUND MANAGEMENT, LLC, D. E. Shaw & Co., Inc., BERKLEY W R CORP, and Polar Asset Management Partners Inc.. This page lists 44 institutional shareholders reporting positions in this security for the Q2 2022 filing period.
Investor Option Weight % Change % Value $ * Price Shares Share Change Activity Report Period
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.